| CLK1 bound with GW807982X (Cpd 8) | | monomer | 148-484 | 99.7 | 2×EDO; 1×PKB; |
|
| Re-refined crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted in… | | monomer | 148-484 | 100.0 | 1×V25; |
|
| CLK1 V324A mutant bound with benzothiazole Tg003 (Cpd 2) | | monomer | 148-484 | 99.41 | 1×EAE; |
|
| CLK1 with bound pyridoquinazoline | | monomer | 148-484 | 99.7 | 1×EDO; 1×FG9; |
|
| CLK1 bound with benzothiazole Tg003 (Cpd 2) | | monomer | 148-484 | 99.7 | 1×EAE; |
|
| Crystal structure of CLK1 in complex with inhibitor 8g | | monomer | 148-483 | 99.7 | 1×E6T; 1×NA; 6×EDO; 1×CL; |
|
| Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h | | monomer | 148-483 | 99.7 | 1×H3E; 12×EDO; |
|
| CLK1 bound with beta-carboline KH-CARB13 (Cpd 3) | | monomer | 148-483 | 99.7 | 2×KHC; |
|
| CLK1 bound with imidazopyridazine (Cpd 1) | | monomer | 148-483 | 99.7 | 1×EDO; 1×IYZ; |
|
| Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound … | | monomer | 148-483 | 99.7 | 5×GOL; 1×6FB; |
|
| CLK1 bound with CAF052 | | monomer | 148-483 | 99.7 | 1×RH8; |
|
| Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound … | | monomer | 148-483 | 99.7 | 1×6FD; 1×GOL; |
|
| Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound VN316 (derivative of compo… | | monomer | 148-483 | 99.7 | 2×PO4; 1×H3Q; 2×GOL; |
|
| Crystal structure of human CLK1 in complex with 10Z-Hymenialdisine | | monomer | 148-482 | 99.7 | 1×DBQ; |
|
| Crystal structure of human CLK1 kinase in complex with compound 3 | | monomer | 148-482 | 99.7 | 1×SO4; 1×XQX; |
|
| Crystal structure of CLK1 in complex with inhibitor 16 | | monomer | 148-482 | 99.7 | 1×E6W; 1×BR; 1×PO4; 3×GOL; 1×NA; |
|
| Crystal structure of CLK1 in complex with compound 2 (CC513) | | monomer | 148-482 | 99.7 | 1×06N; 4×GOL; |
|
| Crystal structure of CLK1 in complex with 5-iodotubercidin | | monomer | 148-482 | 99.7 | 1×5ID; 1×IOD; 1×PO4; |
|
| Crystal structure of CLK1 in complex with macrocycle ODS2004070 | | monomer | 148-482 | 99.7 | 3×PO4; 1×GOL; 1×PQ5; |
|
| Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound VN345 (derivative of compo… | | monomer | 148-482 | 99.7 | 2×GOL; 1×H3H; |
|
| Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine | | monomer | 148-482 | 99.7 | 1×HQB; 1×K; |
|
| Crystal structure of CLK1 in complex with furanopyrimidin VN412 | | monomer | 148-481 | 99.69 | 5×EDO; 1×GOL; 1×H3N; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibi… | | monomer | 148-481 | 99.7 | 1×V25; |
|
| CLK1 Kinase domain with bound imidazopyridin inhibitor TP003 | | monomer | 148-481 | 99.7 | 1×JWN; 1×EDO; |
|
| X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A | | monomer | 148-481 | 100.0 | 1×EAQ; 3×SO4; |
|
| Crystal structure of human CLK1 in complex with Leucettinib-21 | | monomer | 148-481 | 99.7 | 1×WAZ; |
|
| Crystal structure of human CLK1 in complex with Leucettinib-92 | | monomer | 148-481 | 99.69 | 1×WAK; |
|
| Crystal structure of CLK1 in complex with macrocycle ODS2003208 | | monomer | 149-481 | 99.7 | 1×Q7K; 17×EDO; 2×GOL; 1×NA; |
|
| Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang | | monomer | 149-481 | 100 | 1×V25; |
|
| CLK1 bound with ETH1610 (Cpd 17) | | monomer | 150-482 | 99.7 | 4×EDO; 1×7A7; |
|
| Crystal structure of CLK1 in complex with CX-4945 | | monomer | 149-481 | 99.69 | 1×3NG; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 4-(1H-indol-3-yl)pyrimidin-2-amine | | monomer | 152-481 | 100 | 1×V5T; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 4-(1-methyl-1H-indol-3-yl)pyrimid… | | monomer | 152-481 | 100 | 2×JUW; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1H-indol-3-yl)pyr… | | monomer | 152-481 | 100 | 1×JTQ; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 4-(6,7-dichloro-1H-indol-3-yl)pyr… | | monomer | 152-481 | 100 | 1×JQW; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 5-(1-methyl-1H-indol-3-yl)pyrimid… | | monomer | 152-481 | 100 | 1×JU8; |
|
| Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol… | | monomer | 153-481 | 100.0 | 1×JTQ; |
|
| Crystal structure of human CLK1 in complex with compound 25 | | monomer | 155-481 | 99.69 | 1×SQZ; |
|